PreveCeutical Medical (PRVCF) News Today $0.02 0.00 (-12.10%) As of 07/18/2025 02:01 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort InterestBuy This Stock PRVCF Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period PRVCF PreveCeutical Medical Inc. - Seeking AlphaJuly 2, 2025 | seekingalpha.comPreveCeutical Appoints Dr. Francis Tavares as CTO to Enhance Drug Discovery EffortsJune 30, 2025 | tipranks.comPreveCeutical Appoints Dr. Deepak Sampath as Corporate AdvisorJune 2, 2025 | tipranks.comPreveCeutical Appoints Stephen Glover as Corporate Advisor to Boost Strategic GrowthMay 26, 2025 | tipranks.comPreveCeutical Completes Private Placement to Boost R&D EffortsMay 22, 2025 | tipranks.comPreveCeutical’s BioGene Launches New Website to Boost Digital EngagementMay 14, 2025 | tipranks.comPreveCeutical Medical Inc. Announces Launch of New Website for BioGene Therapeutics Inc. ...May 14, 2025 | gurufocus.comPreveCeutical Closes Initial Tranche of Private Placement, Raising $590,001April 28, 2025 | tipranks.comPreveCeutical Upsizes Private Placement to Bolster Financial PositionApril 15, 2025 | tipranks.comPreveCeutical Launches Private Placement to Raise $500,000April 2, 2025 | tipranks.comPreveCeutical Extends Private Placement Deadline to April 2025March 10, 2025 | tipranks.comPreveCeutical Advances Parkinson’s Treatment with Innovative Drug Delivery PlatformFebruary 10, 2025 | tipranks.comPreveCeutical Initiates $300,000 Private Placement to Bolster OperationsJanuary 24, 2025 | tipranks.comPreveCeutical Medical Inc PRVCFMarch 15, 2024 | morningstar.comMPreveCeutical & Endosane Announces Innovative Preclinical Approaches to Assess Brain Availability of CBD And Pharmacologically Relevant Doses Following Intranasal CBD ApplicationSeptember 18, 2023 | finance.yahoo.comPreveCeutical Showcases Dynamic Evolution in AI StrategySeptember 12, 2023 | finance.yahoo.comPreveCeutical Files Two Family Patents of Sol-Gel Cannabinoid Formulation and Antiviral Use & Cyclic Peptides and Uses ThereofJune 28, 2023 | finance.yahoo.comPreveCeutical Medical - Sol-Gel and Uses thereof Patent UpdateMay 30, 2023 | finance.yahoo.comPreveCeutical Medical Launches Clinical Artificial Intelligence DivisionApril 24, 2023 | finance.yahoo.comPreveCeutical Medical Announces Live Interactive Q&A Video ConferenceApril 20, 2023 | finance.yahoo.comPreveCeutical Medical Announces Frontiers Media SA Publication Featuring Data from its Analgesic Program for the Treatment of Peptide-based Therapeutics for Moderate to Severe PainApril 4, 2023 | finance.yahoo.comPreveCeutical Initiates Non-Analgesic (Painkiller) Program, Clinical Development Program & Disclosure CommitteeMarch 20, 2023 | finance.yahoo.comPRVCF PreveCeutical Medical Inc.February 23, 2023 | seekingalpha.comAppointment of C. Evan Ballantyne to PreveCeutical's Board of DirectorsFebruary 21, 2023 | finance.yahoo.comPreveCeutical Awards ICON Analgesic Program (Painkiller) Clinical DevelopmentFebruary 7, 2023 | finance.yahoo.comPreveCeutical, Endosane team up for sol-gel tech use in cannabis therapyJanuary 14, 2023 | msn.comPreveCeutical Enters into License Option Agreement with Endosane PharmaceuticalsJanuary 12, 2023 | finance.yahoo.comPreveCeutical Signs Intercompany Sol-Gel License AgreementJanuary 9, 2023 | finance.yahoo.comThe Power Play by The Market Herald Releases New Interviews with Eloro Resources, Prospera, Datametrex, Gamelancer Media, Infinity Stone Ventures and PreveCeutical Medical Discussing Their Latest NewsNovember 23, 2022 | finance.yahoo.comPreveCeutical Files Application for D-amino Acid PeptidesNovember 21, 2022 | finance.yahoo.comPreveCeutical Medical Inc.: PreveCeutical Announces Conversion of DebtNovember 12, 2022 | finanznachrichten.dePreveCeutical Announces Conversion of DebtNovember 12, 2022 | finance.yahoo.comAppointment of Kathleen Rotika to PreveCeutical's Board of DirectorsOctober 20, 2022 | finance.yahoo.comPreveCeutical Announces Resignation of Board of Director MemberSeptember 16, 2022 | finance.yahoo.comAppointment of Sachin Nanavati to PreveCeutical's Board of DirectorsSeptember 6, 2022 | finance.yahoo.comPreveCeutical Announces Change in Directors and Investor Awareness ServicesMay 27, 2022 | finance.yahoo.comArticle Based on PreveCeutical's Pain Management Peptides Program Published in the British Journal of PharmacologyMay 9, 2022 | finance.yahoo.comPreveCeutical Files International Patent Application for Sol-Gel Cannabinoid Formulation for Antiviral UseNovember 29, 2021 | finance.yahoo.comPreveCeutical Files Provisional Patent Application for D-Amino Acid PeptidesNovember 24, 2021 | finance.yahoo.comPreveCeutical Signs License Agreement for Exclusive Rights to Use UniQuest's Sol-Gel Technology for Delivery of CannabinoidsNovember 18, 2021 | finance.yahoo.comPreveCeutical Receives AU$315,338 Research & Development Tax Incentive Cash RefundAugust 31, 2021 | finance.yahoo.com Get PreveCeutical Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for PRVCF and its competitors with MarketBeat's FREE daily newsletter. Email Address PRVCF Media Mentions By Week PRVCF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRVCF News Sentiment▼0.000.61▲Average Medical News Sentiment PRVCF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRVCF Articles This Week▼00▲PRVCF Articles Average Week Get PreveCeutical Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for PRVCF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Avalo Therapeutics News Century Therapeutics News electroCore News Prelude Therapeutics News Mural Oncology News Acrivon Therapeutics News Iterum Therapeutics News Vivos Therapeutics News Karyopharm Therapeutics News BioNxt Solutions News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:PRVCF) was last updated on 7/21/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PreveCeutical Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PreveCeutical Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRVCF Stock Alerts